CLINICAL_TRIALS
trial_result
· 2021-07-26
Clinical Trial Update: Ofatumumab as Front-Line Therapy in Treating Elderly Participants With Chronic Lymphocytic Leukemia [Phase 2]
Summary
Phase 2 trial update evaluating front-line use of ofatumumab in elderly patients with chronic lymphocytic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2021-07-26